Comparing effect of Viddha-Agnikarma and Iontophoresis in the management of patient suffering from Vatakantaka or Plantar fasciitis or heel pain.

Clinical efficacy of Viddha-Agnikarma and Iontophoresis with Dashmoola kwatha in the management of Vatakantaka (Planter fasciitis): An open labelled randomized comparative clinical trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112002

Enrollment

Registered

2026-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M708- Other soft tissue disorders related to use, overuse and pressure

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from Vatakantaka (Pain in heel region, difficulty in walking and standing) 2. Patients with the age group between 20 to 60 years. 3.Patients fit for Viddha-Agnikarma and Iontophoresis 4.Patient with Calcaneal spur 5. Patient with controlled diabetes mellitus (RBS below 140 mg/dl), controlled hypertension (systolic below 150 mmHg & diastolic below 100 mmHg)

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1 Patient age below 20 years and above 60 years. 2 Patient with fracture and dislocation of ankle joint and calcaneum bone. 3 Patients of uncontrolled diabetes mellitus (RBS above 140 mg/dl), uncontrolled hypertension (systolic above 150 mmHg & diastolic above 100 mmHg), 4 R.A. (Rheumatoid arthritis) positive Gout, Other diseases like Parkinson s disease, severe anemia, malignancies and wounds. 5 Patient having Heartdiseases (IHD, CCF), with pacemaker. 6. Patient with metal implants in the body 7. Patients contraindicated for Viddha-Agnikarma.

Design outcomes

Primary

Measure	Time frame
1.Relief in clinical features of Vatakantaka (Plantar fasciitis) 2.Changes in Plantar fascia thickness Timepoint: 28 days	—

Secondary

Measure	Time frame
Absence of recurrence in follow up periodTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr P B Joshi

ITRA Jamnagar

Pbj@itra.edu.in9427226504

Outcome results